drugset / Trial / NCT00258635

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

NCT00258635 ↗

Phase 2 Completed 69 enrolled Allergy Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the immunological differences between three RagweedMATAMPL treatment arms compared to placebo with respect to immunoglobulin levels. In addition, the study will assess the reduced allergenicity of modified Ragweed Pollen contained in RagweedMATAMPL compared to unmodified native allergen using skin prick testing.

Timeline

Start
2005-11
Primary completion
2006-08-07
Completion
2006-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject RagweedMATAMPL Other / unclassified — —